Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-01-11
2005-01-11
Carlson, Karen Cochrane (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C514S013800, C514S017400, C530S300000, C530S395000, C930S020000, C424S093700, C424S278100
Reexamination Certificate
active
06841532
ABSTRACT:
There is disclosed novel peptides, fragments or analogues thereof and polynucleotides encoding the same, obtained from streptokinase suitable for use in the amelioration of cell death and methods related thereto.
REFERENCES:
patent: 4011142 (1977-03-01), Jacobi
patent: 5286718 (1994-02-01), Elliott
patent: 5917013 (1999-06-01), Rabkin et al.
patent: WO 9407992 (1994-04-01), None
Varshavsky, A. (1996) The N-end rule: functions, mysteries, uses. Proc Natl Acad Sci U S A. vol. 93, pp. 12142-12149. Review.*
Gallus, A. S. (1986) The use of antithrombotic drugs in artery disease. Clin. Haematol. vol. 15, pp. 509-559. (Review).*
Honig, B. (1999) Protein folding: from the levinthal paradox to structure prediction. J. Mol. Biol. vol. 293, pp. 283-293.*
Jackson, K. W. et al. (1982) Complete amino acid sequence of streptokinase and its homology with serine proteases. Biochemistry. vol. 21, pp. 6620-6625.*
Fung et al., “Beneficial Effects of Streptokinase on Left Ventricular Function After Myocardial Reoxygenation and Reperfusion Following Global Ischemia in the Isolated Rabbit Heart,”J. Cardiovasc. Pharmacol.6(3): 429-435, 1984.
Jackson and Tang, “Complete Amino Acid Sequence of Streptokinase and its Homology with Serine Protease, ” Biochemistry 21: 6620-6825, 1982.
Krui,Spectrum: Therapy Markets and Emerging Technologies, Decision Resources, Inc., Waltham Massachusetts, Aug. 18, 1994, “Apoptosis: A New Therapeutic Approach to Cell-Based Disorders.”
Mickelson et al., “Protection of Myocardial Function and Coronary Vasculature by Streptokinase,”J. Cardiovasc. Pharmol.12(2):186-195, 1988.
Rabkin, “Streptokinase But Not TPA Ameliorates a Cellular Response of Cardiomyocytes to Anoxia and Reoxygenation,”Can. J. Cardiol.7(Suppl. A.): p. 80A, Abstract No. 72, 1991.
Krystal Gerald
Rabkin Simon W.
Bieker-Brady Kristina
Carlson Karen Cochrane
Clark & Elbing LLP
CV Molecular Therapeutics Inc.
Lin Samuel W.
LandOfFree
Peptides and their use to ameliorate cell death does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides and their use to ameliorate cell death, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides and their use to ameliorate cell death will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3372562